Endothelial hemostatic predictors of cardiovascular risk in patients with vibration disease in combination with the arterial hypertension
Abstract
About the Authors
L. A. ShpaginaRussian Federation
O. N. Gerasimenko
Russian Federation
V. A. Drobyshev
Russian Federation
G. V. Kuznetsova
Russian Federation
References
1. Boulanger C.M., Vanhoutte, P.M. (2009). The endothelium: a modulator of cardiovascular health and disease. Endothelium, 3(4), 187-203.
2. Deanfield J. (2011). Endothelial function and dysfunction. Hypertension, 23, 7-17.
3. Popova A.A., Mayanskaya S.D., Berezikova E.N., Yakovleva N.F. (2010). Endothelial dysfunction and the mechanisms of its formation. Siberian Medical Review, 4, 7-11.
4. Kuznik B.I. (2010). Cellular and Molecular Mechanisms of Regulation of the Hemostatic System in Health and Disease. Chita: Express Publishing.
5. Lukyanov M.M., Boytsev L.M. (2010). Rigidity of the arterial wall as a factor of cardiovascular risk. Heart, 9, 3 (53), 156-160.
6. Tarasova O.A., Vasilets L.M., Tuev A.V. (2009). Influence of TNFalpha on the formation of structural and functional heart remodeling in patients with atrial fibrillation on the background of hypertension. Cardiovascular Therapy and Prevention, 8 (82), 317-318.
7. Drexler H. Endothelial dysfunction in human disease (2009). The Journal of Molecular and Cellular Cardiology, 31, 51-60.
8. Ehara S. (2011). Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 103, 1955-1961.
Review
For citations:
Shpagina L.A., Gerasimenko O.N., Drobyshev V.A., Kuznetsova G.V. Endothelial hemostatic predictors of cardiovascular risk in patients with vibration disease in combination with the arterial hypertension. Journal of Siberian Medical Sciences. 2017;(1):3-6.